Evidence map›Paper›PMID 34924032›Full record

ArticleChinese neurosurgical journal2021

Bibliometric analysis of China's contribution to the knowledge system of cerebrovascular intervention.

Hongyu Ma, He Li, Peng Liu, Pei Liu, Xiaoxi Zhang, Yongxin Zhang, Zifu Li, Rui Zhao, Bo Hong, Jianmin Liu and 1 more

Abstract read
In one paragraph

Article in Chinese neurosurgical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongyu Ma *
He Li *
Peng LiuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Pei LiuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Xiaoxi ZhangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Yongxin ZhangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Zifu LiNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Rui ZhaoNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Bo HongNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Jianmin LiuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China. chstroke@163.com.
Pengfei YangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China. chyangpf@163.com.

Funding

National Natural Science Foundation of China 81870931the Training Plan of Excellent Talents in Shanghai Municipality Health System 2017YQ034
6 · The paper itself

Abstract

backgroundCerebrovascular disease has become the leading cause of death in China. The purpose of this article is to analyze China's contribution to the interventional treatment of cerebrovascular diseases.

methodsBibliometric analysis was used for evaluating the quantity, quality, research hotspots, and cooperation network of publications regarding interventional treatment of cerebrovascular diseases from China. These articles were searched from the database of Web of Science Core Collection. The authors, publication years, citation times, regions, and source journals of retrieved articles were recorded. Network analysis and visualization were performed on Citespace5.6.

resultsFrom 1991 to 2019, a total of 5052 articles regarding cerebrovascular intervention were contributed by Chinese researchers. The number of publications from China grew fastest annually in the latest 5 years among countries. These publications were cited 61,216 times, with 12.12 average citations per item. The h-index was 82. Affiliated hospitals of Capital Medical University contributed most articles. Cerebral ischemia and intracranial aneurysm were the most popular keywords over the three decades. The timeline view of keywords indicated that cerebral ischemia always was a hot spot. Stent techniques were the main treatment tools and still had a strong developing trend. Neural regeneration and neuroprotection were the hot topics of basic researches related to cerebrovascular intervention.

conclusionsThe number of researches grows rapidly in China over the decades, but the quality still needs further improvement. The increasing contributions of Chinese researchers to the global knowledge system of cerebrovascular intervention are promising.

Indexed as

BibliometricsCerebrovascular disordersEndovascular proceduresInterventional radiologyStroke

Identifiers

PMID34924032
PMCPMC8684789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.